Immune Pharmaceuticals Inc (IMNP)-Medical Equipment-Deals and Alliances Profile
July 2017
28
About the Report
About the Report
Immune Pharmaceuticals Inc (Immune Pharma) formerly EpiCept Corporation, is a pharmaceutical company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and cancer. The company's bertilimumab is under clinical development for moderate to severe ulcerative colitis, crohn's disease and bullous pemphigoid. It also offers nanomabs, which is an antibody nanoparticle conjugate technology platform for the targeted delivery of chemotherapeutics. Immune Pharma's crolibulin is a small molecule vascular disrupting agent that is used for the treatment of solid tumors. The company develops drugs in the areas of immuno oncology, nano-dermatology and neuropathic pain. It has research and development facility in Herzliya-Pituach, Israel. Immune Pharma is headquartered in New York, the US.
Immune Pharmaceuticals Inc (IMNP)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Immune Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Immune Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Immune Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Immune Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Immune Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Immune Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Immune Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Immune Pharma Plans to Raise up to USD3 Million in Public Offering of Shares 10
Immune Pharma Raises USD2 Million in Share Purchase Plan 11
Immune Pharmaceuticals Raises USD9 Million in Private Placement of Series D Redeemable Convertible Preferred Stock 12
Debt Offering 13
Immune Pharma Raises USD1.5 Million in First Tanche of Private Placement of Debentures 13
Immune Pharma Raises USD0.5 Million in Private Placment of 6% Notes Due 2018 14
Immune Pharma Raises USD1 Million in Private Placement of Convertible Notes 14
Immune Pharmaceuticals Inc-Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
May 16, 2016: Immune Pharmaceuticals Provides Business and R&D Update and Announces First Quarter 2016 Financial Results 19
Mar 30, 2016: Immune Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Full Year 2015 Financial Results 20
Corporate Communications 22
Jan 27, 2017: Immune Pharmaceuticals Appoints New Chairman of the Board of Directors 22
Oct 17, 2016: Immune Pharmaceuticals Announces Formation of Management Team for Maxim Pharmaceuticals, its Pain and Neurology Subsidiary 23
Feb 25, 2016: Immune Pharmaceuticals Names Dr. Jeff Paley to its Board of Directors 24
Feb 03, 2016: Immune Pharmaceuticals Names John Neczesny to its Board of Directors 25
Legal and Regulatory 26
Mar 13, 2017: Immune Pharmaceuticals Granted Additional Time to Comply with Nasdaq Listing Requirement 26
Government and Public Interest 27
Apr 24, 2017: Immune Pharmaceuticals Announces Corporate Restructuring 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Figure
List of Figures
Immune Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Immune Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Immune Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Immune Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Immune Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Immune Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Immune Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Immune Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8
List of Table
List of Tables
Immune Pharmaceuticals Inc, Medical Equipment, Key Facts, 2015 1
Immune Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Immune Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Immune Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Immune Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Immune Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8
Immune Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Immune Pharma Plans to Raise up to USD3 Million in Public Offering of Shares 10
Immune Pharma Raises USD2 Million in Share Purchase Plan 11
Immune Pharmaceuticals Raises USD9 Million in Private Placement of Series D Redeemable Convertible Preferred Stock 12
Immune Pharma Raises USD1.5 Million in First Tanche of Private Placement of Debentures 13
Immune Pharma Raises USD0.5 Million in Private Placment of 6% Notes Due 2018 14
Immune Pharma Raises USD1 Million in Private Placement of Convertible Notes 14
Immune Pharmaceuticals Inc, Key Competitors 16
Immune Pharmaceuticals Inc, Key Employees 17
Immune Pharmaceuticals Inc, Other Locations 18
Immune Pharmaceuticals Inc, Subsidiaries 18
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.